EXHIBIT 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 No. 333‑179215, No. 333-162430, No. 333-166249, No. 333-168966, No. 333-162374 and No. 333-173720 and Form S-8 No. 333-173719, No. 333-166813, No. 333-163124, No. 333-151859, No. 333-141738, No. 333-138368, No. 333-118729, No. 333-103129, No. 333-98245 and No. 333-48088 of Raptor Pharmaceutical Corp. of our report dated November 13, 2012, relating to the consolidated financial statements and financial statement schedule of Raptor Pharmaceutical Corp. and its subsidiaries, which report expresses an unqualified opinion and which appears in Raptor Pharmaceutical Corp.'s Transition Report on Form 10-KT/A for the year ended August 31, 2012.

/s/ Burr Pilger Mayer, Inc.

San Francisco, California

May 12, 2014